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Adverse effects of perfluorooctanoic acid 
(PFOA) and related perfluoroalkyl acids on 
pregnancy and development have been sug-
gested based on toxicology (Lau et al. 2007) 
and a small but growing epidemiologic lit-
erature (Steenland et al. 2010). The stron-
gest support from laboratory studies suggests 
the potential for reductions in fetal growth 
(Lau et al. 2007). Epidemiologic findings 
on measures of reduced growth are mixed 
(Apelberg et al. 2007; Fei et al. 2007; Hamm 
et al. 2010; Nolan et al. 2009; Washino et al. 
2009), but generally consistent with a small 
decrement in birth weight associated with 
higher levels of serum PFOA. Duration of 
gestation has not been related to PFOA in 
these same studies (Apelberg et al. 2007; 
Fei et al. 2007; Hamm et al. 2010). More 
extreme, clinically consequential end points 
of fetal growth restriction and preterm birth 
have been examined less extensively and often 
with limited statistical power; none of the 
human studies support an association (Fei 
et al. 2007; Hamm et al. 2010; Nolan et al. 
2009). Given ubiquitous exposure, sugges-
tive toxicologic data, and limited epidemi-
ologic research, continued examination of 
the potential association between PFOA and 
pregnancy outcomes is warranted.
A large population in Ohio and West 
Virginia has been exposed to PFOA predomi-
nantly through industrial contamination of 
drinking-water supplies (Frisbee et al. 2009). 
Within this population, PFOA exposure var-
ies considerably across time and place because 
of different levels of PFOA contamination in 
the drinking water, depending on the year 
and the water district, enabling accurate esti-
mation of serum levels by linking residen-
tial histories and historical drinking-water 
concentrations. The resulting range of PFOA 
levels are well above background exposure 
(Steenland et al. 2009), which may allow for 
a more informative assessment of the impact 
of PFOA exposure on birth outcomes.
For participants in the C8 Health 
Project—a survey conducted in the contami-
nated region (Frisbee et al. 2009)—we pre-
viously analyzed a small number of births 
using serum PFOA measurements (Stein 
et al. 2009) and a much larger number using 
modeling to assign estimated serum PFOA 
levels (Savitz et al. 2012). In this report, we 
used two approaches to evaluate births in 
the region. The first provides comprehen-
sive coverage of the study area, but is subject 
to some exposure misclassification. The sec-
ond sacrifices some of the sample size, but 
has improved exposure measurement. Both 
studies rely on birth certificates for assess-
ment of health end points and use the same 
 environmental/pharmacokinetic models to 
estimate PFOA exposure.
Study I: PFOA and 
Pregnancy Outcome Based 
on Birth Records
Methods
The study area in the mid-Ohio Valley was 
chosen to include PFOA-contaminated public 
water utilities in Mason and Wood counties 
in West Virginia and in Athens, Meigs, and 
Washington counties in Ohio, where levels 
ranged from near U.S. averages to orders of 
magnitude above typical levels (Frisbee et al. 
2009). We obtained computerized live birth 
records with geographic identifiers from the 
Ohio and West Virginia health departments, 
and fetal death records from West Virginia 
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Background: Perfluorooctanoic acid (PFOA) is a potential cause of adverse pregnancy outcomes, 
but previous studies have been limited by low exposures and small study size.
oBjectives: Using birth certificate information, we examined the relation between estimated PFOA 
exposure and birth outcomes in an area of West Virginia and Ohio whose drinking water was con-
taminated by a chemical plant.
Methods: Births in the study area from 1990 through 2004 were examined to generate case groups 
of stillbirth (n = 106), pregnancy-induced hypertension (n = 224), preterm birth (n = 3,613), term 
low birth weight (n = 918), term small-for-gestational-age (SGA) (n = 353), and a continuous 
measure of birth weight among a sample of term births (n = 4,534). A 10% sample of term births 
≥ 2,500 g were selected as a source of controls (n = 3,616). Historical estimates of serum PFOA 
were derived from a previously developed fate and transport model. In a second study, we examined 
4,547 area births linked to a survey with residential history data.
results: In the analysis based only on birth records, we found no consistent evidence of an asso-
ciation between estimated PFOA exposure and stillbirth, pregnancy-induced hypertension, preterm 
birth, or indices of fetal growth. In the analysis of birth records linked to the survey, PFOA was 
unrelated to pregnancy-induced hypertension or preterm birth but showed some suggestion of an 
association with early preterm birth. Measures of growth restriction showed weak and inconsistent 
associations with PFOA.
conclusions: Based on the analysis using the health survey, these results provide little support for 
an effect of PFOA exposure on most pregnancy outcomes, except for early preterm birth and pos-
sibly fetal growth restriction. 
key words: fetal growth restriction, perfluorooctanoic acid, pregnancy, pregnancy-induced hyper-
tension, preterm birth, stillbirth. Environ Health Perspect 120:1201–1207 (2012). http://dx.doi.
org/10.1289/ehp.1104752 [Online 26 March 2012]
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only (unpublished data). We restricted the 
analysis to pregnancies that occurred from 
1990 through 2004 because that is the period 
when the contrasts were highest between 
exposures resulting from contaminant releases 
and background sources (Shin et al. 2011a).
Because of the expense involved with refin-
ing address information and geocoding mater-
nal residences, which is the basis for assigning 
exposure, we used case–control sampling to 
enhance precision for some of the birth out-
comes of interest. We restricted eligibility to 
singleton births and excluded the small pro-
portion (3%) of nonwhite births because 
there were too few to analyze separately. 
Comprehensively identified case groups con-
sisted of stillbirths (fetal death ≥ 20 weeks com-
pleted gestation), preterm births (< 37 weeks 
completed gestation), and term low birth 
weight births (≥ 37 weeks completed gestation 
and birth weight < 2,500 g). A 10% sample of 
term births ≥ 2,500 g (n = 3,616) was selected 
and geocoded for assigning PFOA exposure.
To efficiently select control groups and 
expand the range of birth outcomes, we first 
constructed a stratified 10% random sample 
of the entire population of live births by com-
bining the 10% sample of all term live births 
≥ 2500 g with a 10% random sample of the 
comprehensively identified preterm cases and 
term low birth weight cases (the case groups 
described above) (n = 4063). Pregnancy-
induced hypertension cases, term small-for-
gestational-age (SGA) cases, and term birth 
weight births were identified exclusively from 
the 10% random sample of births. Control 
groups for each of the outcomes were derived 
as noncase subsets from the 10% random 
sample of the entire population of live births.
We conducted a series of case–control 
analyses: a) stillbirths (n = 106) compared with 
West Virginia live births (n = 1,844) because 
stillbirth information was available only from 
West Virginia; b) pregnancy-induced hyper-
tension cases (n = 224) compared with births 
without pregnancy-induced hypertension 
(n = 3,828); c) preterm birth cases < 37 weeks 
(n = 3,613) and < 32 weeks (n = 491) cor-
responding to all preterm and very preterm 
births, respectively, compared with term births 
(n = 3,695), with assignment based on clinical 
assessment of gestational age; d) term low birth 
weight cases (n = 918) compared with term 
births ≥ 2,500 g (n = 3,616); and e) term SGA 
cases [births < 10th percentile by gestational 
age and sex (Oken et al. 2003)] (n = 353) 
compared with term appropriate-for-gesta-
tional-age births [births between the 10th and 
90th percentiles, inclusive, by gestational age 
and sex (Oken et al. 2003)] (n = 2,990). In 
addition, we analyzed a continuous measure of 
birth weight among term births (n = 4,534).
The exposure metric used in the analy-
sis is modeled serum PFOA concentration of 
the mother estimated for the early pregnancy 
period. The methods for estimating individual 
serum PFOA concentrations are described in 
detail elsewhere (Shin et al. 2011a, 2011b). 
Briefly, information on plant operations and 
chemical releases was combined with environ-
mental characteristics of the region through 
a series of linked models to estimate air and 
water concentrations of PFOA from 1951 
through 2008 (Shin et al. 2011a). Geocodes 
for birth residences were used to determine 
whether drinking water in participants’ homes 
was supplied by public water sources or pri-
vate wells. When addresses could be geocoded 
only at the ZIP code level, an average exposure 
measure was calculated based on the propor-
tion of the ZIP code population that was sup-
plied by contaminated drinking water. With 
these estimated environmental levels of PFOA 
based on the geocoded maternal address, indi-
vidual maternal serum levels for each preg-
nancy were estimated using age- and sex-based 
pharmacokinetic modeling with standard 
assumptions about water intake, body weights, 
and a PFOA half-life (Shin et al. 2011b).
Because we had only the residence listed 
on the birth certificate for the mother—not 
a residential history—and serum levels at a 
given time depend on exposure history, we 
assumed that she had lived in this location for 
the previous 6 years, which would account for 
approximately 63% of her serum concentra-
tion given a stable exposure rate and an esti-
mated serum half-life of PFOA of 3.5 years 
(Olsen et al. 2007). Moving within the same 
public water supply district would have little 
or no impact on the estimated serum values, 
but moving across water districts or especially 
from more distant locations would lead to 
exposure misclassification.
We were able to geocode the maternal 
address listed on the birth certificate to the 
street level for 66% of births and to the ZIP 
code level for the remaining 34%, with lit-
tle variation in these proportions by case or 
control status. We found a high correlation 
between the exposure estimate using street 
level geocode and ZIP code averages (r = 0.84), 
indicating modest loss of information from 
lack of street level assignment. To make opti-
mal use of the available data, we used the ZIP 
code average exposure and other information 
from the birth certificate (maternal educa-
tion, maternal age, parity, tobacco use, expo-
sure year, residential state) to impute a new 
exposure estimate for the pregnancies with ZIP 
code geocodes only (n = 2,780). We used mul-
tiple imputation to generate 20 replications to 
obtain accurate information on the variability 
in the imputed values (Graham et al. 2007). 
Markov Chain Monte Carlo imputation was 
used with 200 burn-in iterations and 100 itera-
tions between each imputation. The parameter 
estimates and standard errors determined from 
each imputed data set were pooled into a final 
parameter estimate and variance (Rubin 1987). 
Missing covariate data on maternal age (n = 2), 
maternal education (n = 61), parity (n = 6), 
and tobacco use (n = 64) were also imputed. 
The primary analyses incorporate the exposure 
estimates for the street-level geocode (66%) 
and the imputed exposure estimate when only 
ZIP code geocodes could be assigned (34%). 
In sensitivity analyses we considered the impact 
of restricting to births with exposure estimates 
based on street-level geocodes only and no 
missing covariate data.
Estimated serum PFOA concentrations 
were generated by calendar year, with the rele-
vant exposure year for each pregnancy consid-
ered to be month 3 of gestation for stillbirths 
and month 4 for live births. The estimated 
serum PFOA level at the time of pregnancy 
was skewed, so we considered serum PFOA 
estimates as a continuous log-transformed 
measure, a continuous untransformed mea-
sure, and in quintiles of exposure. We aggre-
gated the lowest two quintiles as the reference 
category for analysis because those quintiles 
covered a modest range typical of U.S. serum 
levels and our exposure estimates are best able 
to differentiate individual exposure at higher 
levels resulting from consumption of locally 
contaminated water.
We adjusted all analyses for maternal age 
(splines with 3 degrees of freedom), education 
(< 12, 12, 13–15, ≥ 16 years), parity (0, 1, 
≥ 2), tobacco use (smoker, nonsmoker), expo-
sure year (splines with 4 degrees of freedom), 
and state of residence (Ohio, West Virginia). 
In addition, we included gestational age 
(37, 38, 39, 40, 41, ≥ 42 completed weeks) 
as a covariate in the analysis of birth weight 
among term births.
For the binary outcomes, we used logistic 
regression to estimate the odds ratio (OR) and 
95% confidence interval (CI) associated with 
PFOA exposure, using the log-transformed 
value to generate ORs for an interquartile 
shift from the 25th to 75th percentile, and the 
untransformed variable used to generate ORs 
per 100-ng/mL shift and for quintiles (com-
paring the 3rd, 4th, and 5th with the aggre-
gated 1st and 2nd quintiles). Both crude and 
adjusted effect estimates were generated. We 
used multiple linear regression to estimate the 
association between PFOA and birth weight, 
using the same measures of estimated PFOA 
exposure described for the categorical out-
comes. All statistical analyses were conducted 
using SAS version 9.2 (SAS Institute Inc., 
Cary, NC) and R version 2.12.1 (R Project 
for Statistical Computing, Vienna, Austria).
Results
Births were nearly evenly divided by calendar 
period and by state (Table 1). Estimated expo-
sure to PFOA tended to be higher for births 
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that were more recent, among older mothers, 
more highly educated mothers, nonsmokers, 
and West Virginia residents (Table 1).
Stillbirth was unrelated to PFOA expo-
sure based on either continuous or categorical 
exposure measures (Table 2). Although there 
was some suggestion of an increased risk based 
on the untransformed measure (OR = 1.20 
per 100 ng/mL; 95% CI: 0.86, 1.68), the lack 
of gradient across quintiles does not support 
an association. Pregnancy-induced hyperten-
sion was unrelated to PFOA exposure regard-
less of metric (Table 2). Preterm birth was not 
associated with PFOA (Table 3).
PFOA was not related to risk of term 
low birth weight, with some suggestion of 
a reduced risk of SGA with higher exposure 
but no gradient across quintiles (Table 4). 
Birth weight among term births was largely 
unrelated to estimated PFOA (Table 4). 
There was a suggestion of a modest decrease 
Table 1. Study I: PFOA and pregnancy outcome based on birth records: characteristics of study population by pregnancy outcome, Mid-Ohio Valley, 
1990–2004 [n (%)].
Maternal 
characteristic Stillbirth PIH
Preterm 
< 37 weeks Term LBW SGA All births
Estimated PFOA among 
all births (ng/mL) 
median (25th, 75th percentiles)
Total 106 224 3,613 918 353 8,253 7.7 (4.9, 17.2)
Exposure year
1990–1994 28 (26) 51 (23) 1,068 (30) 295 (32) 117 (33) 2,685 (33) 7.0 (4.5, 17.7)
1995–1999 49 (46) 84 (38) 1,170 (32) 312 (34) 124 (35) 2,776 (34) 7.9 (5.0, 16.4)
2000–2004 29 (27) 89 (40) 1,375 (38) 311 (34) 112 (32) 2,792 (34) 8.2 (5.0, 17.6)
State of residence
WV 88 (83) 111 (50) 1,470 (41) 401 (44) 157 (44) 3,610 (44) 10.2 (5.3, 19.8)
OH 18 (17)a 113 (50) 2,143 (59) 517 (56) 196 (56) 4,643 (56) 6.3 (4.6, 13.4)
Age (years)
< 20 18 (17) 29 (13) 602 (17) 186 (20) 75 (21) 1,330 (16) 6.7 (4.7, 13.5)
20–24 39 (37) 67 (30) 1,187 (33) 321 (35) 138 (39) 2,743 (33) 7.2 (4.9, 16.4)
25–29 23 (22) 69 (31) 949 (26) 209 (23) 77 (22) 2,185 (26) 8.4 (4.9, 18.9)
30–34 17 (16) 44 (20) 572 (16) 128 (14) 46 (13) 1,346 (16) 8.5 (4.9, 19.8)
≥ 35 9 (8) 15 (7) 303 (8) 74 (8) 17 (5) 649 (8) 8.4 (4.9, 19.7)
Education (years)
< 12 21 (20) 24 (11) 772 (21) 273 (30) 113 (32) 1,701 (21) 6.9 (4.8, 14.3)
12 51 (48) 94 (42) 1,518 (42) 389 (42) 134 (38) 3,435 (42) 7.5 (4.9, 17.3)
13–15 24 (23) 67 (30) 865 (24) 167 (18) 68 (19) 1,996 (24) 8.3 (4.9, 19.8)
≥ 16 10 (9) 39 (17) 458 (13) 89 (10) 38 (11) 1,121 (14) 8.3 (5.0, 17.2)
Parity
0 49 (46) 137 (61) 1,710 (47) 457 (50) 178 (50) 3,801 (46) 7.6 (4.9, 16.7)
1 29 (27) 46 (21) 1,104 (31) 271 (30) 102 (29) 2,668 (32) 7.7 (4.9, 17.1)
≥ 2 28 (26) 41 (18) 799 (22) 190 (21) 73 (21) 1,784 (22) 7.6 (4.8, 18.2)
Smoking status
Smoker 27 (25) 32 (14) 1,039 (29) 430 (47) 167 (47) 2,364 (29) 7.0 (4.8, 15.1)
Nonsmoker 79 (75) 192 (86) 2,574 (71) 488 (53) 186 (53) 5,889 (71) 8.0 (4.9, 18.1)
Abbreviations: PIH, Pregnancy-induced hypertension; LBW, low birth weight. 
aSome Ohio residents delivered stillbirths in West Virginia.
Table 2. Study I: PFOA and pregnancy outcome based on birth records: association of PFOA with stillbirth and pregnancy-induced hypertension, Mid-Ohio 
Valley, 1990–2004.
Stillbirth Pregnancy-induced hypertension
Estimated PFOA
Live birthsa 
(n)
Cases 
(n)
Crude 
OR
Adjustedb  
OR (95% CI)
Live births 
(n)
Cases 
(n)
Crude 
OR
Adjustedb  
OR (95% CI)
IQR(lnPFOA)c increase 1,844 106 0.92 1.00 (0.76, 1.32) 3,828 224 1.06 1.02 (0.86, 1.21)
100-ng/mL increase 1,844 106 1.01 1.20 (0.86, 1.68) 3,828 224 1.06 1.06 (0.86, 1.31)
< 40th percentile (1.0 to < 6.1 ng/mLd ) 504 35 1.0 1.0 1,527 82 1.0 1.0
40th to < 60th percentile (6.1 to < 10.2 ng/mL) 330 15 0.9 0.9 (0.4, 2.0) 764 48 1.2 1.0 (0.7, 1.6)
60th to < 80th percentile (10.2 to < 21.0 ng/mL) 487 31 1.1 1.0 (0.5, 1.7) 759 51 1.1 1.0 (0.6, 1.5)
≥ 80th percentile (21.0 to 717.6 ng/mL) 523 25 0.7 0.8 (0.5, 1.5) 778 43 1.1 1.0 (0.7, 1.5)
aWest Virginia only. bAdjusted for maternal age, education, parity, smoking status, exposure year, state of residence. cEffect estimates represent the change in outcome for a shift from 
the 25th percentile to the 75th percentile in estimated PFOA serum levels [IQR(lnPFOA) = 1.50]. dThe category boundaries are from the first imputed data set.
Table 3. Study I: PFOA and pregnancy outcome based on birth records: association of PFOA with preterm birth, Mid-Ohio Valley, 1990–2004.
< 37 weeks gestation < 32 weeks gestation
Estimated PFOA
Term births 
(n)
Cases 
(n)
Crude 
OR
Adjusteda 
OR (95% CI)
Cases 
(n)
Crude 
OR
Adjusteda 
OR (95% CI)
IQR(lnPFOA)b increase 3,695 3,613 0.99 1.02 (0.96, 1.08) 491 0.95 0.98 (0.86, 1.11)
100-ng/mL increase 3,695 3,613 1.01 1.02 (0.94, 1.10) 491 0.88 0.90 (0.74, 1.10)
< 40th percentile (1.0 to < 6.1 ng/mLc) 1,460 1,467 1.0 1.0 197 1.0 1.0
40th to < 60th percentile (6.1 to < 10.2 ng/mL) 755 720 1.0 1.0 (0.8, 1.1) 108 1.0 1.0 (0.7, 1.4)
60th to < 80th percentile (10.2 to < 21.0 ng/mL) 733 714 1.0 1.0 (0.9, 1.2) 95 1.0 1.1 (0.8, 1.4)
≥ 80th percentile (21.0 to 717.6 ng/mL) 747 712 1.0 1.0 (0.9, 1.2) 91 0.9 1.0 (0.7, 1.3)
aAdjusted for maternal age, education, parity, smoking status, exposure year, state of residence. bEffect estimates represent the change in outcome for a shift from the 25th percentile 
to the 75th percentile in estimated PFOA serum levels [IQR(lnPFOA) = 1.50]. cThe category boundaries are from the first imputed data set.
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in birth weight with higher exposure based 
on continuous exposure measures {somewhat 
stronger for male births [see Supplemental 
Material, Table 1 (http://dx.doi.org/10.1289/
ehp.1104752)]}, but no monotonic gradi-
ent across quintiles. In the sensitivity analysis 
restricted to the 66% of births with street-level 
geocodes and complete covariate informa-
tion (see Supplemental Material, Tables 2–4), 
results were largely unchanged except for gen-
erating weak positive associations with both 
pregnancy-induced hypertension and late 
preterm births.
Study II: PFOA and 
Pregnancy Outcome Based 
on Birth Records Linked to the 
C8 Health Project
Methods
The C8 Health Project enrolled > 69,000 resi-
dents of the mid-Ohio Valley who were part of 
a class action lawsuit, administered a question-
naire eliciting health and residential history 
information, and collected blood to measure 
serum levels of perfluoroalkyl acids and clini-
cal health markers. Geocoding had already 
been attempted for every residential address in 
the C8 Health Project (Shin et al. 2011b).
We sought to link births from 1990–2004 
birth certificates in a 13-county region in West 
Virginia (Cabell, Jackson, Mason, Pleasants, 
Putnam, Ritchie, Wirt, and Wood counties) 
and Ohio (Athens, Gallie, Meigs, Morgan, and 
Washington counties) to self-reported births 
in the C8 Health Project. This 13-county 
region encompasses the 5 counties included in 
study I. We considered a match to be accurate 
based on consistency between the birth cer-
tificate and C8 Health Project information for 
one of three combinations: a) mother’s county 
and state of residence + mother’s date of birth 
+ month and year of infant’s birth + infant’s 
sex; b) mother’s county and state of residence 
+ mother’s age + mother’s first name, middle 
initial, last name + month and year of infant’s 
birth + infant sex; or c) mother’s county and 
state of residence + mother’s address + mother’s 
age + month and year of infant’s birth + infant 
sex. This process yielded 3,323 matched births. 
We extended the matching through the West 
Virginia Birth Score project, a program of the 
West Virginia Department of Health (2012) 
to identify infants at risk of developmental 
problems. Using the mother’s Social Security 
number as well as other birth certificate items, 
Birth Score was able to identify an additional 
1,224 matched births through 2004, yielding a 
total of 4,547 birth certificates linked to the C8 
Health Project for analysis.
We used the same environmental/
pharmaco kinetic models from study I to gen-
erate annual exposure estimates, except that 
the link to the C8 Health Project enabled us 
to incorporate lifetime residential history, thus 
reducing exposure misclassification (Shin et al. 
2011a, 2011b). We examined the  model-based 
exposure estimates, a Bayesian time-dependent 
calibration in which the measured 2005–2006 
serum concentration was used for updat-
ing estimates (Savitz et al. 2012), and a tra-
ditional calibration method assuming that 
a higher-than-expected 2005–2006 serum 
concentration reflects an entire lifetime of 
higher-than-expected exposure. As in study I, 
we considered a log-transformed continuous 
measure, an untransformed continuous mea-
sure, and quintiles, aggregating the lowest two 
quintiles as the referent. Pregnancy outcomes 
and covariates were defined as described for 
study I. We used generalized estimating 
equations with an exchangeable correlation 
structure to account for correlation across a 
woman’s multiple pregnancies.
Results
As in study I, PFOA exposures were higher in 
the more recent time period, among older and 
more highly educated mothers, and among 
nonsmokers; however, in study II expo-
sures were higher for Ohio births than West 
Virginia births, presumably reflecting the dif-
ferent geographic scope of the two studies 
(Table 5).
Pregnancy-induced hypertension showed 
essentially no association with estimated serum 
PFOA based on the uncalibrated estimates 
(Table 6). With Bayesian calibration, the log-
transformed and categorical measures sug-
gested a positive association, with an increased 
risk primarily in the 4th quintile. Traditional 
calibration showed elevated risk in the 3rd and 
4th quintiles, but the continuous exposure 
measures did not indicate an association.
Preterm birth < 37 weeks was weakly 
related to PFOA levels based on continuous 
measures in the uncalibrated analyses, but 
with no gradient across quintiles (Table 7). 
Bayesian calibration yielded a similar pattern 
and traditional calibration yielded no asso-
ciation. Preterm birth < 32 weeks, with only 
40 cases, showed some suggestion of an associ-
ation without calibration, enhanced somewhat 
with traditional calibration, and markedly 
strengthened with Bayesian calibration.
Term low birth weight was largely unre-
lated to PFOA based on exposure measures 
without calibration, except for an isolated 
increased risk in the 4th quintile (Table 8). 
With both calibration methods, the log-
 transformed continuous measure showed a 
stronger association than the untransformed 
continuous measure. There were also irregular 
findings across quintiles, but none suggestive of 
a monotonic gradient. Term SGA was weakly 
associated with increasing PFOA levels based 
on continuous and categorical exposures across 
all exposure estimates (Table 8). The continu-
ous birth weight analysis yielded some support 
for an association (Table 8), with a predicted 
decrement of 22 g for an interquartile shift 
in exposure (95% CI: –46, 2.1 g), and decre-
ments of 25 g (95% CI: –64, 13 g) and 33 g 
(95% CI: –73, 6.5 g) in the fourth and fifth 
quintiles of exposure based on the uncalibrated 
exposure estimates. This pattern was similar for 
the Bayesian calibrated estimates and somewhat 
reduced with traditional calibration. No sex 
differences were apparent [see Supplemental 
Material, Table 5 (http://dx.doi.org/10.1289/
ehp.1104752)].
Table 4. Study I: PFOA and pregnancy outcome based on birth records: association of PFOA with indicators of fetal growth, Mid-Ohio Valley, 1990–2004.
Term low birth weight Term SGA Change in term birth weight (g)
Estimated PFOA
Term births  
≥ 2,500 g (n)
Cases 
(n)
Crude 
OR
Adjusteda  
OR (95% CI)
Term AGA 
(n)
Cases 
(n)
Crude 
OR
Adjusteda 
OR (95% CI)
Cases 
(n)
Crude 
difference
Adjusteda 
difference (95% CI)
IQR(lnPFOA)b increase 3,616 918 0.96 1.02 (0.92, 1.13) 2,990 353 0.85 0.91 (0.78, 1.06) 4,534 3.20 –10.72 (–32.26, 10.82)
100-ng/mL increase 3,616 918 0.91 1.00 (0.86, 1.15) 2,990 353 0.78 0.86 (0.67, 1.11) 4,534 6.44 –14.80 (–43.28, 13.68)
< 40th percentile  
(1.0 to < 6.1 ng/mL)c
1,420 378 1.0 1.0 1,172 148 1.0 1.0 1,798 0 0 (referent)
40th to < 60th percentile  
(6.1 to < 10.2 ng/mL)
741 176 0.9 0.9 (0.7, 1.2) 600 81 1.0 1.0 (0.7, 1.4) 917 21.3 22.8 (–32.9, 78.5)
60th to < 80th percentile  
(10.2 to < 21.0 ng/mL)
717 188 1.0 1.0 (0.8, 1.3) 596 69 1.0 1.0 (0.7, 1.5) 905 –9.6 2.3 (–50.3, 54.8)
≥ 80th percentile  
(21.0 to 717.6 ng/mL)
738 176 0.9 1.0 (0.8, 1.3) 622 55 0.7 0.8 (0.6, 1.2) 914 10.9 –9.5 (–58.4, 39.4)
AGA, appropriate for gestational age. 
aAdjusted for maternal age, education, parity, smoking status, exposure year, state of residence, gestational age (Term birth weight analysis only). bEffect estimates represent the change 
in outcome for a shift from the 25th percentile to the 75th percentile in estimated PFOA serum levels [IQR(lnPFOA) = 1.50]. cThe category boundaries are from the first imputed data set.
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Discussion
In study I, PFOA and Pregnancy Outcome 
Based on Birth Records, we found little indi-
cation of an association between PFOA and 
stillbirth, pregnancy-induced hypertension, 
preterm birth, or indicators of fetal growth. 
These analyses had the advantage of relative 
freedom from selection bias and large study 
size, but exposure was estimated based only on 
the residential address reported on the birth 
certificate rather than a lifetime residential his-
tory. Study II, PFOA and Pregnancy Outcome 
Based on Birth Records Linked to the C8 
Health Project, yielded sporadic positive asso-
ciations but little overall support for an associa-
tion with pregnancy-induced hypertension or 
preterm birth< 37 weeks, modest support for 
an association with indicators of fetal growth 
restriction, and strong but imprecise indications 
of an association with preterm birth < 32 weeks. 
These analyses incorporated better estimates of 
exposure by using lifetime residential history, 
but a smaller sample size and the potential for 
selection bias from incomplete matching of 
birth certificates to the C8 Health Project.
Study I and study II differ in several ways, 
including comprehensiveness and precision, but 
exposure assignment is probably most influen-
tial: Study II had residential history information 
for reconstructing exposure, and study I did 
not. Among the participants in both studies 
(n = 626), the Spearman rank order correlation 
coefficient between the exposure estimate based 
on reported lifetime residential history versus 
just the maternal residence on the birth cer-
tificate was 0.64, reflecting a modest correlation 
and a clear loss of accuracy in study I.
There is some overlap between the births 
included in the two studies given the shared 
geographic scope. More than 70% of preterm 
and term low birth weight cases in study II 
were also included in study I because of the 
comprehensive assessment of these case groups 
in study I. Fewer than 8% of all study I births, 
however, were included in study II.
Integrating these findings into the litera-
ture, there are three previous studies in this 
geographic area (Nolan et al. 2009; Savitz et al. 
2012; Stein et al. 2009) as well as other studies 
of PFOA and birth outcomes (Apelberg et al. 
2007; Fei et al. 2007; Hamm et al. 2010). The 
study by Nolan et al. (2009) addressed births 
in 2003–2005 in Washington County, Ohio, 
comparing birth weight and preterm birth risk 
among residents of ZIP codes with varying 
levels of PFOA in the water.
Stillbirth was examined in our previ-
ous analysis of C8 Health Project partici-
pants (Savitz et al. 2012) and neither Savitz 
et al. (2012) nor the present study suggested 
an association with PFOA. Preeclampsia 
was weakly associated with PFOA exposure 
in other analyses of this population (Savitz 
et al. 2012; Stein et al. 2009). Study I showed 
essentially no association between PFOA and 
pregnancy-induced hypertension, whereas 
study II provided modest support, primarily 
with calibrated exposure estimates. Among 
all pregnancy outcome measures, pregnancy-
 induced hypertension is the most vulnerable to 
inconsistent definitions and inaccurate report-
ing. The C8 Health Project addresses self-
reported “preeclampsia” (Savitz et al. 2012; 
Stein et al. 2009) and birth certificates code 
“pregnancy-induced hypertension,” although 
there is likely to be misclassification in both 
Table 5. Study II: PFOA and pregnancy outcome based on birth records linked to the C8 Health Project: 
characteristics of the study population, Mid-Ohio Valley, 1990–2004 [n (%)].
Maternal 
characteristic PIH
Preterm 
< 37 weeks Term LBW SGA All births
Estimated PFOA among 
all births (ng/mL)  
[median (25th, 75th percentiles)]
Total 250 405 99 362 4,547 13.4 (5.6, 61.2)
Exposure year
1990–1994 53 (21) 77 (19) 28 (28) 105 (29) 1,296 (29) 7.2 (4.6, 42.8)
1995–1999 110 (44) 142 (35) 31 (31) 121 (33) 1,674 (37) 13.7 (5.9, 65.7)
2000–2004 87 (35) 186 (46) 40 (40) 136 (38) 1,577 (35) 18.3 (7.6, 63.2)
State of residence
West Virginia 150 (60) 227 (56) 64 (65) 213 (59) 2,735 (60) 10.4 (5.3, 44.6)
Ohio 100 (40) 178 (44) 35 (35) 149 (41) 1,812 (40) 23.9 (6.6, 81.2)
Age (years)
< 20 32 (13) 51 (13) 19 (19) 66 (18) 541 (12) 8.8 (5.0, 33.7)
20–24 82 (33) 124 (31) 37 (37) 149 (41) 1,514 (33) 10.8 (5.3, 46.0)
25–29 77 (31) 118 (29) 23 (23) 81 (22) 1,320 (29) 15.6 (5.8, 73.1)
30–34 46 (18) 79 (20) 18 (18) 51 (14) 855 (19) 19.0 (6.3, 74.6)
≥ 35 13 (5) 33 (8) 2 (2) 15 (4) 317 (7) 23.0 (6.3, 106.1)
Education (years)
< 12 26 (10) 65 (16) 24 (24) 86 (24) 605 (13) 8.6 (5.1, 23.1)
12 109 (44) 176 (43) 46 (46) 157 (43) 1,970 (43) 11.3 (5.2, 50.3)
13–15 67 (27) 110 (27) 17 (17) 83 (23) 1,309 (29) 18.7 (6.3, 79.6)
≥ 16 48 (19) 54 (13) 12 (12) 36 (10) 663 (15) 22.4 (6.3, 84.2)
Parity
0 167 (67) 189 (47) 52 (53) 189 (52) 2,007 (44) 11.9 (5.5, 52.8)
1 50 (20) 143 (35) 24 (24) 108 (30) 1,652 (36) 15.6 (5.8, 70.0)
≥ 2 33 (13) 73 (18) 23 (23) 65 (18) 888 (20) 13.2 (5.4, 61.5)
Smoking status
Smoker 20 (8) 96 (24) 40 (40) 154 (43) 870 (19) 10.2 (5.2, 32.4)
Nonsmoker 230 (92) 309 (76) 59 (60) 208 (57) 3,677 (81) 14.7 (5.7, 68.1)
Abbreviations: PIH: pregnancy-induced hypertension; LBW, low birth weight. 
Table 6. Study II: PFOA and pregnancy outcome based on birth records linked to the C8 Health Project: 
association of PFOA with pregnancy-induced hypertension, Mid-Ohio Valley, 1990–2004.
Estimated PFOA
Live births 
(n)
Cases 
(n)
Crude 
OR
Adjusteda 
OR (95% CI)
Uncalibrated
IQR(lnPFOA)b increase 3,905 250 1.08 1.05 (0.85, 1.31)
100-ng/mL increase 3,905 250 0.98 1.01 (0.91, 1.12)
< 40th percentile (3.9 to < 8.9 ng/mL) 1,632 96 1.0 1.0
40th to < 60th percentile (8.9 to < 21.8 ng/mL) 778 52 1.1 1.0 (0.7, 1.4)
60th to < 80th percentile (21.8 to 83.3 ng/mL) 736 52 1.2 1.1 (0.7, 1.5)
≥ 80th percentile (83.3 to 921.3 ng/mL) 759 50 1.1 1.1 (0.8, 1.5)
Bayesian calibration
IQR(lnPFOA)c increase 3,905 250 1.11 1.13 (0.92, 1.37)
100-ng/mL increase 3,905 250 0.92 0.97 (0.85, 1.11)
< 40th percentile (3.9 to < 8.9 ng/mL) 1,635 88 1.0 1.0
40 to < 60th percentile (8.9 to < 19.6 ng/mL) 757 46 1.1 1.0 (0.7, 1.4)
60 to < 80th percentile (19.6 to 53.1 ng/mL) 735 67 1.7 1.5 (1.1, 2.1)
≥ 80th percentile (53.1 to 1897.0 ng/mL) 778 49 1.2 1.2 (0.8, 1.7)
Traditional calibration
IQR(lnPFOA)d increase 3,905 250 1.01 1.03 (0.87, 1.22)
100-ng/mL increase 3,905 250 0.83 0.89 (0.75, 1.06)
< 40th percentile (0.05 to < 11.4 ng/mL) 1,628 82 1.0 1.0
40th to < 60th percentile (11.4 to < 21.0 ng/mL) 759 63 1.6 1.5 (1.1, 2.2)
60th to < 80th percentile (21.0 to 49.0 ng/mL) 729 62 1.7 1.5 (1.1, 2.2)
≥ 80th percentile (49.0 to 2468.4 ng/mL) 789 43 1.1 1.1 (0.8, 1.7)
aAdjusted for maternal age, education, parity, smoking status, exposure year, state of residence. bEffect estimates rep-
resent the change in outcome for a shift from the 25th percentile to the 75th percentile in estimated PFOA serum levels 
[IQR(lnPFOA) = 2.39]. cEffect estimates represent the change in outcome for a shift from the 25th percentile to the 75th 
percentile in estimated PFOA serum levels [IQR(lnPFOA) = 1.92]. dEffect estimates represent the change in outcome for a 
shift from the 25th percentile to the 75th percentile in estimated PFOA serum levels [IQR(lnPFOA) = 1.61].
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data sources. Pregnancy-induced hypertension 
refers to elevated blood pressure with or with-
out protein in the urine; preeclampsia spe-
cifically requires proteinuria. When compared 
with medical records, birth certificates yield 
sensitivity and positive predictive values < 50% 
(DiGiuseppe et al. 2002; Lydon-Rochelle et al. 
2005). These largely negative findings should 
be tempered by recognition of substantial 
 outcome misclassification.
Evaluation of preterm birth in previous 
studies (Fei et al. 2007; Hamm et al. 2010) 
was hampered by small numbers of cases 
and yielded little evidence of an association. 
Previous reports on preterm birth in this study 
area, whether based on serum measures in 
recent pregnancies (Stein et al. 2009), histori-
cal exposure estimates among larger numbers 
Table 7. Study II: PFOA and pregnancy outcome based on birth records linked to the C8 Health Project: association of PFOA with preterm birth, Mid-Ohio Valley, 
1990–2004.
< 37 weeks gestation < 32 weeks gestation
Estimated PFOA
Term births 
(n)
Cases 
(n)
Crude 
OR
Adjusteda 
OR (95% CI)
Cases 
(n)
Crude 
OR
Adjusteda 
OR (95% CI)
Uncalibrated
IQR(lnPFOA)b increase 4,142 405 1.13 1.09 (0.91, 1.32) 40 1.16 1.29 (0.74, 2.23)
100-ng/mL increase 4,142 405 1.06 1.09 (1.00, 1.18) 40 1.00 1.10 (0.86, 1.40)
< 40th percentile (3.9 to < 8.9 ng/mL) 1,669 150 1.0 1.0 13 1.0 1.0
40th to < 60th percentile (8.9 to < 21.8 ng/mL) 810 99 1.4 1.2 (0.9, 1.5) 12 1.9 1.5 (0.7, 3.5)
60th to < 80th percentile (21.8 to 83.3 ng/mL) 841 68 0.9 0.8 (0.6, 1.1) 7 1.1 0.9 (0.4, 2.4)
≥ 80th percentile (83.3 to 921.3 ng/mL) 822 88 1.2 1.2 (0.9, 1.6) 8 1.2 1.4 (0.5, 3.6)
Bayesian calibration
IQR(lnPFOA)c increase 4,142 405 1.09 1.10 (0.92, 1.31) 40 1.33 1.67 (1.03, 2.70)
100-ng/mL increase 4,142 405 1.06 1.12 (1.02, 1.23) 40 1.06 1.25 (1.02, 1.52)
< 40th percentile (3.9 to < 8.9 ng/mL) 1,666 153 1.0 1.0 10 1.0 1.0
40th to < 60th percentile (8.9 to < 19.6 ng/mL) 820 89 1.2 1.0 (0.8, 1.3) 9 1.8 1.5 (0.6, 4.1)
60th to < 80th percentile (19.6 to 53.1 ng/mL) 827 82 1.1 0.9 (0.7, 1.3) 12 2.4 2.3 (1.0, 5.5)
≥ 80th percentile (53.1 to 1897.0 ng/mL) 829 81 1.1 1.0 (0.8, 1.4) 9 1.8 2.3 (0.9, 5.7)
Traditional calibration
IQR(lnPFOA)d increase 4,142 405 0.98 0.95 (0.82, 1.11) 40 1.17 1.33 (0.86, 2.07)
100-ng/mL increase 4,142 405 0.99 1.03 (0.94, 1.13) 40 1.01 1.13 (0.97, 1.32)
< 40th percentile (0.05 to < 11.4 ng/mL) 1,649 170 1.0 1.0 13 1.0 1.0
40th to < 60th percentile (11.4 to < 21.0 ng/mL) 831 78 0.9 0.8 (0.6, 1.1) 7 1.0 1.0 (0.4, 2.6)
60th to < 80th percentile (21.0 to 49.0 ng/mL) 825 84 1.0 0.9 (0.7, 1.1) 14 2.1 2.1 (1.0, 4.5)
≥ 80th percentile (49.0 to 2468.4 ng/mL) 837 73 0.9 0.9 (0.6, 1.2) 6 0.9 1.2 (0.4, 3.1)
aAdjusted for maternal age, education, parity, smoking status, exposure year, state of residence. bEffect estimates represent the change in outcome for a shift from the 25th percentile 
to the 75th percentile in estimated PFOA serum levels [IQR(lnPFOA) = 2.39]. cEffect estimates represent the change in outcome for a shift from the 25th percentile to the 75th percentile 
in estimated PFOA serum levels [IQR(lnPFOA) = 1.92]. dEffect estimates represent the change in outcome for a shift from the 25th percentile to the 75th percentile in estimated PFOA 
serum levels [IQR(lnPFOA) = 1.61].
Table 8. Study II: PFOA and pregnancy outcome based on birth records linked to the C8 Health Project: association of PFOA with indicators of fetal growth, Mid-
Ohio Valley, 1990–2004.
Term low birth weight Term SGA  
 Change in term birth weight (g)
Estimated PFOA
Term births 
≥ 2,500 g 
(n)
Cases 
(n)
Crude 
OR
Adjusteda 
OR (95% CI)
Term, 
AGA 
(n)
Cases 
(n)
Crude 
OR
Adjusteda 
OR (95% CI)
Cases 
(n)
Crude 
difference
Adjusteda 
difference (95% CI)
Uncalibrated
IQR(lnPFOA)b increase 4,043 99 0.87 1.04 (0.75,1.44) 3,375 362 1.02 1.18 (0.97, 1.43) 4,142 0.97 –21.89 (–45.91, 2.13)
100-ng/mL increase 4,043 99 0.93 1.00 (0.82,1.21) 3,375 362 1.01 1.07 (0.98, 1.17) 4,142 4.27 –9.14 (–20.30, 2.02)
< 40th percentile (3.9 to < 8.9 ng/mL) 1,629 40 1.0 1.0 1,356 144 1.0 1.0 1,669 0 0 (referent)
40th to < 60th percentile (8.9 to < 21.8 ng/mL) 791 19 0.9 0.9 (0.5, 1.7) 659 72 1.0 1.0 (0.7, 1.4) 810 –19.9 –3.8 (–40.4, 32.8)
60th to < 80th percentile (21.8 to 83.3 ng/mL) 814 27 1.4 1.6 (1.0, 2.8) 689 76 1.0 1.1 (0.8, 1.6) 841 –30.4 –25.4 (–63.7, 12.9)
≥ 80th percentile (83.3 to 921.3 ng/mL) 809 13 0.7 0.9 (0.5, 1.7) 671 70 1.0 1.3 (0.9, 1.7) 822 4.9 –33.3 (–73.1, 6.5)
Bayesian calibration
IQR(lnPFOA)c increase 4,043 99 0.97 1.16 (0.86,1.58) 3,375 362 1.03 1.19 (1.00, 1.43) 4,142 7.78 –21.51 (–43.62, 0.61)
100-ng/mL increase 4,043 99 0.93 1.04 (0.85,1.27) 3,375 362 0.98 1.06 (0.97, 1.16) 4,142 3.73 –18.55 (–31.31, –5.80)
< 40th percentile (3.9 to < 8.9 ng/mL) 1,624 42 1.0 1.0 1,358 148 1.0 1.0 1,666 0 0 (referent)
40th to < 60th percentile (8.9 to < 19.6 ng/mL) 803 17 0.8 0.8 (0.4, 1.5) 676 68 0.9 0.9 (0.7, 1.3) 820 –15.8 10.8 (–24.9, 46.5)
60th to < 80th percentile (19.6 to 53.1 ng/mL) 803 24 1.1 1.3 (0.7, 2.2) 664 74 1.0 1.1 (0.8, 1.5) 827 –9.0 –11.0 (–49.8, 27.8)
≥ 80th percentile (53.1 to 1897.0 ng/mL) 813 16 0.8 1.0 (0.6, 1.9) 677 72 1.0 1.3 (0.9, 1.7) 829 8.7 –32.3 (–71.5, 6.8)
Traditional calibration
IQR(lnPFOA)d increase 4,043 99 1.16 1.33 (1.04,1.69) 3,375 362 1.05 1.17 (1.00, 1.36) 4,142 2.45 –16.90 (–34.89, 1.08)
100-ng/mL increase 4,043 99 1.00 1.07 (0.96,1.18) 3,375 362 1.03 1.08 (1.01, 1.16) 4,142 4.54 –12.76 (–26.08, 0.57)
< 40th percentile (0.05 to < 11.4 ng/mL) 1,614 35 1.0 1.0 1,351 147 1.0 1.0 1,649 0 0 (referent)
40th to < 60th percentile (11.4 to < 21.0 ng/mL) 817 14 0.8 0.8 (0.4, 1.5) 686 70 0.9 1.0 (0.7, 1.3) 831 –9.2 4.2 (–31.2, 39.6)
60th to < 80th percentile (21.0 to 49.0 ng/mL) 793 32 1.8 2.2 (1.3, 3.6) 659 72 1.0 1.1 (0.8, 1.5) 825 1.1 1.8 (–37.7, 41.4)
≥ 80th percentile (49.0 to 2468.4 ng/mL) 819 18 1.1 1.4 (0.8, 2.5) 679 73 1.0 1.2 (0.9, 1.7) 837 22.7 –21.2 (–59.6, 17.2)
AGA, appropriate for gestational age. 
aAdjusted for maternal age, education, parity, smoking status, exposure year, state of residence, gestational age (term birth weight analysis only). bEffect estimates represent the 
change in outcome for a shift from the 25th percentile to the 75th percentile in estimated PFOA serum levels [IQR(lnPFOA) = 2.39]. cEffect estimates represent the change in outcome 
for a shift from the 25th percentile to the 75th percentile in estimated PFOA serum levels [IQR(lnPFOA) = 1.92]. dEffect estimates represent the change in outcome for a shift from the 
25th percentile to the 75th percentile in estimated PFOA serum levels [IQR(lnPFOA) = 1.6].
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of C8 Health Project pregnancies (Savitz et al. 
2012), or geographic analyses of exposed ZIP 
codes (Nolan et al. 2009) are consistent in 
showing an absence of association. Study I 
likewise showed no evidence of an associa-
tion, but the findings in study II are more 
ambiguous. Preterm birth < 37 weeks had at 
most modest suggestions of an association, 
whereas preterm birth < 32 weeks generated 
large and imprecise elevations in risk, mark-
edly strengthened by Bayesian calibration to 
estimate exposure. Although the size of the 
associations warrant attention, the role of ran-
dom error and instability across exposure mea-
sures must also be taken into account.
Previous analyses of reduced birth weight 
have focused largely on continuous birth 
weight measures rather than on low birth 
weight or SGA. Studies of other populations 
have had limited ability to precisely examine 
extreme levels of birth weight and have found 
no support for an association with PFOA (Fei 
et al. 2007; Hamm et al. 2010). Two previous 
studies provided support for an association 
between continuous measures of PFOA and 
birth weight (Apelberg et al. 2007; Fei et al. 
2007), and two smaller studies provided less 
precise statistical indications of modest reduc-
tions in birth weight with increasing levels of 
PFOA (Hamm et al. 2010; Washino et al. 
2009). Previous analyses in the Mid-Ohio 
Valley showed little indication of an effect of 
PFOA on fetal growth (Nolan et al. 2009; 
Savitz et al. 2012; Stein et al. 2009), but stud-
ies based on just the C8 Health Project (Savitz 
et al. 2012; Stein et al. 2009) were unable to 
examine a continuous measure of birth weight. 
In study I, there was some indication of decre-
ments in birth weight associated with increas-
ing PFOA levels, particularly for male births in 
the categorical analysis. In study II, all growth 
indicators—term low birth weight, term SGA, 
and a continuous measure of birth weight—
showed small, inconsistent suggestions of a 
possible association, which is comparable with 
the previous reports.
There are a number of issues to consider 
with regard to possible decrements in birth 
weight associated with PFOA exposure. First, 
the studies of typical levels of PFOA (Apelberg 
et al. 2007; Fei et al. 2007) yield associations 
that are similar to our effect sizes even though 
we examined a much greater range of exposure. 
If there is a causal effect in which the impact 
is linear at both very low and very high expo-
sures, we would have expected the larger abso-
lute exposure contrasts in the present study 
to yield stronger associations than those from 
studies of a narrower exposure range. Second, 
the previous studies examining typical serum 
levels of PFOA during pregnancy were sus-
ceptible to distortion by relying on exposure 
measures that reflect the uptake, metabolism, 
and excretion of PFOA, and may therefore 
share some physiologic determinants of birth 
weight (Longnecker 2006). In contrast, expo-
sure assignments in the present study (except 
for the calibrated estimates in study II) were 
based on distinctive sources of environmental 
contamination and were unaffected by physi-
ologic differences in PFOA metabolism. Third, 
the physiologic or clinical relevance of these 
small shifts in birth weight is uncertain, pos-
sibly serving as a marker of subtle toxicity, but 
not of direct importance to health. Not only 
are the implications of low birth weight subject 
to varying interpretations (Wilcox 2001), but 
shifts within the normal range, which drives 
the association because most births are within 
the normal range, are even more questionable 
as markers of adverse impacts on health.
The limitations in these data warrant com-
ment, with most issues applicable to both stud-
ies. Birth certificates are a useful, if imperfect, 
source of data on pregnancy outcome: Birth 
weight is generally accurate, more so than ges-
tational age (DiGiuseppe et al. 2002), with 
pregnancy-induced hypertension the most fal-
lible outcome. Information on potential con-
founders was limited to basic demographic 
information and smoking, though the spatial 
manner in which the exposure was distributed 
makes strong confounding by socioeconomic 
or behavioral factors unlikely. Even the expo-
sure estimates based on full residential histo-
ries in study II are subject to error, given the 
inability to predict with precision the levels 
of contaminants in drinking water at a given 
place and time, individual variability in water 
use and PFOA pharmacokinetics, and inac-
curacies in dates and locations of self-reported 
residences. The magnitude of these errors is 
exacerbated in study I because of the absence of 
longitudinal information on residential history.
Overall, we found little support for PFOA 
having adverse effects on pregnancy-induced 
hypertension or preterm birth in the aggre-
gate; modest and inconsistent evidence of 
reduced fetal growth; and large, imprecise 
indications of an association with early pre-
term birth. The irregularity across exposure 
indices and susceptibility to inconsistent 
variation based on calibration tempers the 
suggestions of possible causal effects on these 
pregnancy outcomes. The potential associa-
tion of PFOA with small decrements in birth 
weight is of unknown significance, but is 
perhaps the most readily amenable to more 
refined studies for continued investigation, 
with studies of preterm birth < 32 weeks, a 
rare outcome, requiring nested case–control 
studies based on stored serum for exposure 
assessment. If an impact on birth weight is 
causal, which is yet to be established, it reflects 
a biological process that is worth elucidating 
even if not of direct health concern.
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